Wells Fargo’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-13,203
| Closed | -$27K | – | 7715 |
|
2021
Q3 | $27K | Sell |
13,203
-15
| -0.1% | -$31 | ﹤0.01% | 5551 |
|
2021
Q2 | $39K | Sell |
13,218
-553,916
| -98% | -$1.63M | ﹤0.01% | 5340 |
|
2021
Q1 | $1.57M | Buy |
567,134
+371,956
| +191% | +$1.03M | ﹤0.01% | 3680 |
|
2020
Q4 | $475K | Buy |
195,178
+52,610
| +37% | +$128K | ﹤0.01% | 4474 |
|
2020
Q3 | $300K | Buy |
142,568
+23,469
| +20% | +$49.4K | ﹤0.01% | 4577 |
|
2020
Q2 | $451K | Buy |
119,099
+14,039
| +13% | +$53.2K | ﹤0.01% | 4286 |
|
2020
Q1 | $199K | Buy |
105,060
+13,980
| +15% | +$26.5K | ﹤0.01% | 4531 |
|
2019
Q4 | $192K | Buy |
91,080
+5,517
| +6% | +$11.6K | ﹤0.01% | 4816 |
|
2019
Q3 | $204K | Buy |
85,563
+32,211
| +60% | +$76.8K | ﹤0.01% | 4772 |
|
2019
Q2 | $168K | Sell |
53,352
-27,330
| -34% | -$86.1K | ﹤0.01% | 4876 |
|
2019
Q1 | $401K | Buy |
80,682
+13,513
| +20% | +$67.2K | ﹤0.01% | 4400 |
|
2018
Q4 | $300K | Buy |
67,169
+24,318
| +57% | +$109K | ﹤0.01% | 4514 |
|
2018
Q3 | $207K | Buy |
42,851
+630
| +1% | +$3.04K | ﹤0.01% | 4808 |
|
2018
Q2 | $253K | Sell |
42,221
-81,127
| -66% | -$486K | ﹤0.01% | 4747 |
|
2018
Q1 | $1.09M | Buy |
123,348
+78,708
| +176% | +$696K | ﹤0.01% | 3788 |
|
2017
Q4 | $324K | Buy |
44,640
+41,012
| +1,130% | +$298K | ﹤0.01% | 4561 |
|
2017
Q3 | $24K | Buy |
+3,628
| New | +$24K | ﹤0.01% | 5354 |
|